RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
GUIDANCE FINAL
Concept paper on the guideline revision on good pharmacogenomic practice
Published: 10/6/2026Detected: 10/6/2026

Summary preview

Revises EMA’s good pharmacogenomic practice framework to reflect advancing genomics technologies and to improve regulatory usability across medicines development and clinical use.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
oncology
cardiology
neurology
immunology
infectious_disease
rare_diseases
pediatrics
dermatology
psychiatry
hematology

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Committee for Orphan Medicinal Products (COMP): 6-8 October 202610/12/2026
  • Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
  • First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
  • Committee for Medicinal Products for Human Use (CHMP): 12-15 October 202610/12/2026
  • Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
gastroenterology
ophthalmology
respiratory
clinical
quality
safety
clinical
labeling
#pharmacogenomics
#long-read sequencing
#DNA variants
#phenotype-genotype correlation
#pharmacogenomic study design
  • Security
  • Privacy Policy
  • Terms of Service

    • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.